Welcome to our dedicated page for Geron SEC filings (Ticker: GERN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Geron鈥檚 SEC disclosures is no small task. Clinical trial footnotes, preferred stock conversions, and imetelstat milestones sprawl across hundreds of pages. Investors searching 鈥淕eron quarterly earnings report 10-Q filing,鈥� 鈥淕eron insider trading Form 4 transactions,鈥� or simply 鈥淕eron SEC filings explained simply鈥� often spend hours hunting for one number: cash runway. Our platform removes that friction.
Stock Titan鈥檚 AI-powered summaries pinpoint the R&D burn rate, partnership revenue, and trial progress buried in every document. Whether you need 鈥淕eron 8-K material events explained鈥� after an unexpected efficacy update or a 鈥淕eron annual report 10-K simplified鈥� before your valuation model, we translate technical jargon into plain English within seconds. AG真人官方-time alerts stream 鈥淕eron Form 4 insider transactions real-time,鈥� flagging when executives adjust positions so you never miss a signal.
From proxy to prospectus, every filing type is covered:
- 10-K and 10-Q: drill into segment spending with 鈥淕eron earnings report filing analysis鈥�.
- Form 4: monitor 鈥淕eron executive stock transactions Form 4鈥� for buying or selling trends.
- DEF 14A: review 鈥淕eron proxy statement executive compensation鈥� without spreadsheets.
- 8-K: catch material trial announcements the moment they hit EDGAR.
Use our expert insights to compare quarter-over-quarter R&D shifts, assess dilution risk from new equity offerings, and understand pipeline milestones鈥攁ll without sifting through medical jargon. If you鈥檝e ever searched 鈥渦nderstanding Geron SEC documents with AI,鈥� you鈥檝e just found the answer.
Harout Semerjian, President & CEO and a director of Geron Corp (GERN), received stock option grants on 08/07/2025 totaling 11,000,000 options exercisable into common stock at an exercise price of $1.30 per share and expiring on 08/06/2035. The awards are direct beneficial ownership and were reported on a Form 4.
The grants vest in two schedules: one award of 7,000,000 options vests with 875,000 shares on February 7, 2026 and the remaining 6,125,000 in 42 equal monthly installments beginning February 7, 2026; a second award of 4,000,000 options vests with 1,000,000 shares on August 7, 2026 and the remaining 3,000,000 in 36 equal monthly installments beginning August 7, 2026, provided the optionee continues to provide services to the Company. These details describe the size, price, expiry and service鈥慶onditioned vesting of the executive option grants.
Event: Geron Corporation (GERN) filed an 8-K reporting the appointment of Harout Semerjian as President, Chief Executive Officer and director, effective August 7, 2025.
- CEO appointment: Mr. Semerjian replaces Dawn C. Bir and will fill a Class I board vacancy through the 2027 annual meeting.
- Compensation: Annual base salary $800,000; annual performance target bonus 70% of base salary (prorated for 2025).
- Equity inducement: Grant of stock options to purchase 11,000,000 shares under the 2018 Inducement Award Plan; exercise price = Nasdaq closing price on start/grant date.
- Vesting: 7,000,000 options: 12.5% at six months then monthly over 42 months; 4,000,000 options: 25% at one year then monthly over 36 months; full vest upon Change in Control.
- Severance: Covered Termination: prorated target bonus, lump-sum equal to 18 months base salary, COBRA for up to 18 months; vested options remain exercisable until earlier of two years post-termination or original expiration.
- Plan amendments: Amended and Restated Severance Plan effective August 1, 2025 adds a CEO payment equal to 150% of target bonus upon a qualifying Change of Control; 2018 Inducement Award Plan amended to add 11,000,000 shares for inducement grants.
- Exhibits: Employment Agreement (Exhibit 10.1), Amended Severance Plan (Exhibit 10.2), Amended 2018 Inducement Plan (Exhibit 10.3).
FAQ
What is the current stock price of Geron (GERN)?
What is the market cap of Geron (GERN)?
